March 16, 2010 (Atlanta, Georgia) — Genotyping warfarin patients resulted in a 30% reduction in all-cause hospitalizations and hospitalizations for bleeds/thromboemboli, a new study suggests.
FOR LATEST UPDATES, CLICK TO JOIN OUR WHATS APP GROUP >>
CLICK HERE TO SUBSCRIBE, PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
Production JobsR&D JobsF&D JobsSales & MarketingQA JobsQC JobsFaculty JobsCRO JobsDRA JobsIPR JobsIT JobsPackaging AlertsHospital Pharmacist